• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5080429)   Today's Articles (5078)
For: Chemaitelly H, Ayoub HH, Tang P, Coyle PV, Yassine HM, Al Thani AA, Al-Khatib HA, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. History of primary-series and booster vaccination and protection against Omicron reinfection. Sci Adv 2023;9:eadh0761. [PMID: 37792951 PMCID: PMC10550237 DOI: 10.1126/sciadv.adh0761] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/08/2023] [Accepted: 07/26/2023] [Indexed: 10/06/2023]
Number Cited by Other Article(s)
1
Wrynla XH, Bates TA, Trank-Greene M, Wahedi M, Hinchliff A, Curlin ME, Tafesse FG. Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination. COMMUNICATIONS MEDICINE 2025;5:182. [PMID: 40382525 PMCID: PMC12085693 DOI: 10.1038/s43856-025-00898-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2024] [Accepted: 05/07/2025] [Indexed: 05/20/2025]  Open
2
Augello M, Bono V, Rovito R, Tavelli A, Santoro A, Tincati C, Vergori A, Azzini AM, Righi E, Spiteri G, Porru S, Meschi S, Notari S, Maggi F, Antinori A, Tacconelli E, d'Arminio Monforte A, Marchetti G. Long-term immune responses to SARS-CoV-2 Omicron BA.4/5 mRNA booster in people living with HIV. COMMUNICATIONS MEDICINE 2025;5:92. [PMID: 40148493 PMCID: PMC11950219 DOI: 10.1038/s43856-025-00799-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2024] [Accepted: 03/07/2025] [Indexed: 03/29/2025]  Open
3
Sukik L, Chemaitelly H, Ayoub HH, Coyle P, Tang P, Hasan MR, Yassine HM, Al Thani AA, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt A, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severities. BMJ Open Respir Res 2025;12:e002718. [PMID: 40139840 PMCID: PMC11950940 DOI: 10.1136/bmjresp-2024-002718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2024] [Accepted: 03/14/2025] [Indexed: 03/29/2025]  Open
4
Chemaitelly H, Ayoub HH, Coyle P, Tang P, Hasan MR, Yassine HM, Al Thani AA, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron. Nature 2025;639:1024-1031. [PMID: 39910292 PMCID: PMC11946897 DOI: 10.1038/s41586-024-08511-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2024] [Accepted: 10/16/2024] [Indexed: 02/07/2025]
5
Wrynla XH, Bates TA, Trank-Greene M, Wahedi M, Hinchliff A, Curlin ME, Tafesse FG. Immune imprinting and vaccination interval underly XBB.1.5 monovalent vaccine immunogenicity. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2025:2025.02.09.25321965. [PMID: 40034787 PMCID: PMC11875258 DOI: 10.1101/2025.02.09.25321965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/05/2025]
6
Chemaitelly H, Ayoub H, Coyle P, Tang P, Hasan M, Yassine H, Al Thani A, Al‐Kanaani Z, Al‐Kuwari E, Jeremijenko A, Kaleeckal A, Latif A, Shaik R, Abdul‐Rahim H, Nasrallah G, Al‐Kuwari M, Butt A, Al‐Romaihi H, Al‐Thani M, Al‐Khal A, Bertollini R, Abu‐Raddad L. BNT162b2 Versus mRNA-1273 Vaccines: Comparative Analysis of Long-Term Protection Against SARS-CoV-2 Infection and Severe COVID-19 in Qatar. Influenza Other Respir Viruses 2024;18:e13357. [PMID: 39343986 PMCID: PMC11439586 DOI: 10.1111/irv.13357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2024] [Revised: 06/19/2024] [Accepted: 07/04/2024] [Indexed: 10/01/2024]  Open
7
Jiang J, Lau EHY, Zhou Z, Yin G, Lin Y, Cowling BJ, Lam KF. Assessing the Impact of Primary-Series Infection and Booster Vaccination on Protection against Omicron in Hong Kong: A Population-Based Observational Study. Vaccines (Basel) 2024;12:1014. [PMID: 39340044 PMCID: PMC11435694 DOI: 10.3390/vaccines12091014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2024] [Revised: 08/31/2024] [Accepted: 09/03/2024] [Indexed: 09/30/2024]  Open
8
Poh XY, Lee IR, Tan CW, Chavatte JM, Fong SW, Goh YS, Rouers A, Wong N, Torres-Ruesta A, Mah SYY, Yeoh AYY, Gandhi M, Rahman N, Chin YQ, Lim JJ, Yoong TJK, Rao S, Chia PY, Ong SWX, Lee TH, Sadarangani SP, Lin RJH, Lim DRX, Chia W, Renia L, Ren EC, Lin RTP, Lye DC, Wang LF, Ng LFP, Young BE. First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial. EBioMedicine 2024;107:105275. [PMID: 39137572 PMCID: PMC11367514 DOI: 10.1016/j.ebiom.2024.105275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2024] [Revised: 07/14/2024] [Accepted: 07/27/2024] [Indexed: 08/15/2024]  Open
9
Sukik L, Chemaitelly H, Ayoub HH, Coyle P, Tang P, Yassine HM, Al Thani AA, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abdel-Rahman ME, Abu-Raddad LJ. Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient. Vaccine 2024;42:3307-3320. [PMID: 38616439 DOI: 10.1016/j.vaccine.2024.04.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/29/2024] [Revised: 04/01/2024] [Accepted: 04/04/2024] [Indexed: 04/16/2024]
10
Hansen CH. Evidence of immune imprinting or the effect of selection bias? SCIENCE ADVANCES 2023;9:eadk5668. [PMID: 37792936 PMCID: PMC10550216 DOI: 10.1126/sciadv.adk5668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/06/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA